If you have colorectal cancer that has spread to other areas of the body, your healthcare provider may prescribe Vectibix® (panitumumab) to help slow down the progression of the cancer. This medicine is specifically approved for use in adults who have not adequately responded to other chemotherapy treatments. It is also designed for use in the treatment of cancer that has a certain protein, known as epidermal growth factor receptor (EGFR), on the surface of the cancer cells.
Vectibix comes as a liquid that is given slowly into a vein using an intravenous (IV) infusion. A healthcare provider will administer the medicine every 14 days.
Before starting treatment with Vectibix, make sure to review the medication's safety information with your healthcare provider. For example, you may not be able to use this drug if you have certain allergies, lung disease, or a history of electrolyte abnormalities.
Although some people do not experience any problems with Vectibix, most people will develop some type of side effect, such as abdominal (stomach) pain, fatigue, or skin reactions.
(Click Vectibix for more information on this medication, including how it works, details on safety and effectiveness, and dosing guidelines.)
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click